Luke Judge

hundo

hundo is an immersive on-demand content platform where young people can discover the future of learning and work. Bringing an on-chain skills wallet to help users prove their learning credentials, and employers find their future talent.

Backed by Outlier Ventures, Moscar, Ascension, and Microsoft for Startups.

tangoo

Non Executive Director - International Growth

◯ accelerate agency

accelerate was born out of our passion for data, content and SEO. accelerate has works with major SaaS brands, consistently delivering impressive results; namely, growth and ROI.

Non Executive Director

tactical.

Board Advisor

Outlier Ventures

Startup Mentor - Polygon

Addesu

Startup Mentor

Avallen Spirits

Digital Marketing Advisor

Tapx

Tapx connects Web3 users with innovative new Blockchain partners in a secure and rewarding way. It is a Web3-enabled business with a mobile app and platform built using the Polygon blockchain, designed to give people earning and control over their personal data, with privacy and security by design.

Backed by Outlier Ventures

incuBeta

CEO - Incubeta UK and North America

Following a period of International Crisis Volunteer Work, I am delighted to rejoin the NMPi team as Managing Director. I aim to lead the business through an ambitious growth plan, expanding the company's global footprint into international markets, and diversifying its digital marketing service offering.

Managing Director

Adventure Travel and Volunteering

International Crisis Volunteer Work

Luke Judge is a respected digital expert, with a proven track record of delivering success and growth in the area of digital marketing. His expertise is sought across the industry, as both a speaker at conferences and as a judge for digital marketing awards.

Luke is the Chief Executive Officer of Tapmydata, an innovative Web3 company that enables new Blockchain partners to connect with authenticated users in a rewarding way. It is a Blockchain-enabled business with a mobile app and platform built using the Polygon network, designed to give people earning and control over their personal data, with privacy and security by design.

Along with a team of experienced blockchain developers, we will deliver an ambitious transformation plan for Tapmydata.

Luke was formerly the CEO of Incubeta UK and US, comprising the award winning media agency, NMPi; programmatic AdTech consultancy, DQ&A; and digital creative specialist, Joystick. He led the company through ambitious expansion to increase their global footprint for it's digital advertising solutions, helping national and global brands to maximise their potential online. 

Luke expanded the brand to an additional 12 offices in 9 markets, and introduced new analytics, SEO, DCX, and creative propositions to the company's solution offerings. 

Prior to the Incubeta role, Luke has long been a member of the NMPi team, joining what was then called Net Media Planet in 2008 as International Business Development Manager. He quickly established himself as an integral part of the company’s early success. After 4 years of growth within the company, Luke took on the role of Sales and Marketing Director, where he proved pivotal in scaling and accelerating the business. 

Before his career at NMPi, Luke worked for Aspire as their Digital Media Team Manager, after having started his professional digital marketing career with BMW GB.. 

Luke also took some time away from his career to travel and volunteer. He led the formation and growth of an independent volunteer group which aided refugees who were fleeing from war torn countries like Syria and Yemen.

Luke Judge - hundo

Galino Labs

As founder of Galino Labs, I am building what the industry lacked: a strategic nerve center where behavioral science meets deal-making muscle. 

We don't just advise - we rewire decision-making for biotech CEOs, investors and scientific leaders drowning in uncertainty.

Why 93% of strategic initiatives fail (and how we fix it):

- We implant behavioral science frameworks (prospect theory, pre-mortem analysis) that:
• Turn analysis paralysis into decisive M&A moves
• Convert risk aversion into calculated aggression
• Transform boardroom debates into aligned action within 3 meetings


Our proprietary intelligence engine, the "Signal House™", tracks what others miss:
• Hidden leverage points in R&D commercialization
• Clinical trial cost budgeting and design
• Portfolio blind spots distorting billion-dollar decisions

I am building Galino Labs, as the next business powerhouse in the life sciences industry with my expert collaborators, to deliver what leaders actually need:

• For founders, it is the "alchemy" that will turn science into irresistible investment narratives
• For investors, the "A Lens" to spot the 10X outliers before term sheets arrive
• For scientific leaders, the boardroom playbook to transition from lab genius to a commercial strategist

Our 3 brand pillars are:

Signal Intelligence → We see first, act fastest
Decision Engineering → Behavioral science meets dealmaking
Founder DNA → Built by operators, for operators

Are you building the strategic infrastructure for biotech's next decade?

Claim your edge and shoot me a DM!

Founder & Decision Architect

freelancer

Small pipettes shouldn’t mean small thinking. 

Beyond Galino Labs, I arm emerging bioscience founders with Fortune 500-caliber strategies.

Why?
 

Because breakthrough science deserves breakthrough commercial thinking.

Here’s where I change the game and the 3 high-impact solutions that come with it:

Market-focused due diligence - My scientific assessments don’t just evaluate technology, they blueprint commercialization pathways before your first funding round.

"Forward-look" business architecture -  My goal is to design business models that convert scientific promise into irresistible investment propositions.

Precision market navigation - No more wandering the "valley of death." I plot your route to market with the certainty of a Phase III clinical trial endpoint.

What makes this work? 

I’m fluent in both the language of peer review and the dialect of investor pitches. 

My frameworks help innovators anticipate market shifts before they appear on competitors’ radars. 

Most importantly:

I transform your data into strategic decisions so compelling they feel inevitable.

This isn’t consulting. This is strategic enablement for science pioneers.

Life Sciences Business Analyst

Genopole

The SHAKER program by Genopole, France's leading biocluster, is an innovative incubator designed for early-stage biotech entrepreneurs.

As a mentor in this program, my major role is to provide entrepreneurial insights to the biotech projects involved.

On top of that, bi-monthly I will be giving presentations to the student-founders on topics related to:

- Identifying the Biotech Market Needs
- Life Sciences Business Scaling-Up
- Conceptualizing Business Models
- Bringing Forward Their Value Proposition

My whole experience so far has been very rewarding, as I find great fulfilment by mentoring the founders that are part of the program.

SweetBlocks

As a Co-Founder at SweetBlocks, I was the second go-to-mastermind working behind the scenes, orchestrating every quirky detail of our revolutionary protocol that focuses on gamified web3 tokenomics, a concept that is exciting and still nascent in the space.

With a daring entrepreneurial  spirit and a passion for cutting-edge technology, I worked closely with our talented cross-functional team to ensure that our internal processes are delivered with ingenuity.

From inception to delivery, together with my colleague Marco Piccioli, we were setting our sights high and leading the charge to bring our bold vision to life. 

I thrive on the challenge of delivering unparalleled ideas in every aspect of our projects.

With a keen eye for detail and a sharp mind for risk management, I stayed one step ahead of the game, identifying potential issues and devising solutions before they become roadblocks.

Unfortunately, tough market times and our strong conviction in bootstrapping the project did not work out and the project has been deceased, hence I learnt tons on product ideation, design and project management.

Co-Founder

Nous Systems

Business Development (Partnerships)

Zoetis UK

I had the opportunity to work at PetMedix, an Animal Health company, that was successfully acquired by Zoetis (the world's leading animal health company).

At PetMedix, under the supervision of Dr. Marco Bardelli, I was involved in the R&D department, where the aim was the ideation of therapeutic mAbs (design and bioengineering) for companion animals, where my work included:

-CHO culture preparation for mAbs expression
-Antibody design bioengineering
-Transfection
-Protein Purification and Characterization (Chromatographic Techniques - HPLC & IEX)
-Protein Stress Tests 
-ELISA and SDS-PAGE assays

Research Associate

Cignpost Diagnostics Ltd.

Previously Scientist for onsight COVID-19 testing at Cignpost Diagnostics Ltd  (Heathrow Airport). 

It was fun (at times) and hectic, but definitely learnt a lot from my colleagues during the pandemic times by seeing their work ethos.

Scientist

National Food Institute, Technical University of Denmark

Student research assistant in the lab of Prof. Egon Bech Hansen, where my work was two fold:

1)  The computational discovery of proteases that can hydrolyse a specific region of potato's total proteasome.

This task has been followed by:

-Using already established bioinformatics tools that are readily available on the web
-Identification of interesting peptides from potato  protein that have potential food applications, and not only.
-In silico investigation of the features that potato protein possesses and how those can be exploited further downstream in the process.

2) The promoter expression level assaying of several Lactococcus strains, with a focus on the expression of a particular outer-membrane protease, named PrtP. 

The focus was on:

-Developing fastidious minimal media for the growth of L. lactis. This objective will support the main goal which is to create a growth substrate that can support the discovery of novel L. lactis mutants that acommodate mutations prefereably on the PrtP protease.
-Potato protein hydrolyzation through the mutants and identification of their specific characteristics ( 
through sequencing, checking the proteolysis pattern  and the optimal protease functioning conditions ).

Research Assistant

International Hellenic University

My thesis' project had as a major aim to identify the potential antimicrobial activity of several newly synthesized chemical compounds that could target the DNA gyrase of Escherichia coli. 

As Molecular Docking was our virtual screening method for identifying the most promising candidate compounds, diverse open-source bioinformatics tools have been used in order to succeed in discovering those that could be further studied not only in silico but also in vitro.

Noteworthy is that fact that the library of our tested ligands had been given for virtual screening through our collaborators at the Aristostle University of Thessaloniki, precisely from the School of Pharmacy of the same institution.

Supervisor: Associate Professor Phaedra Eleftheriou

Grade: 10/10

Research Thesis

Weizmann Institute of Science

I won a scholarship from the Kupcinet-Getz International Summer Science School Program of
Weizmann’s Institute in Israel, to conduct research at the lab of Dr. Ilana Kolodkin-Gal’s, in the Department of Molecular Genetics. 

My project had to do with the expression level assessment of SKF, an allelopath cannibalism toxin in Bacillus subtilis. To assess SKF’s expression level, B. subtilis during growth was treated with the root exudates of various plants.

Kupcinet-Getz International Summer Science School Fellow

Web3 Research and Insights Analyst | We're Building a DeFi Game-of-Luck | Blockchain Design Thinker

I am a Life Sciences business analyst who has a big passion for bioentrepreneurship and understanding the biotech market's dynamics in a holistic manner.

I am focusing on bringing value to founders and operators of mainly small-medium bioentreprises that request my work.

I have a knack for:

- Investigating and extrapolating biotech business data for identifying your needs
- Unlocking the full potential of possible bio-assets that can be commercialized
- Understanding in depth the decision-making process of bio-companies
- Sourcing targeted data through systematic research

My passion for technology and science leads my life into exploring what is possible to achieve by combining principles from biotechnology, business, behavioural psychology and the philosophy of science.

Seeking the missing link between your biotech innovation and market success? 

Follow and connect with me here, and find out how I connect these crucial "industry dots" by bringing front-stage the best of what you can and need to do to achieve an edge in your niche market in the biotech industry.

I am available to do analysis work for bigger established biotech (& pharma) companies, VC/PE firms that invest in the life sciences industry, and consultancy firms.

Do you want to contact me?

Either easily send me a DM here, or send an email at athanasios.tsagkadouras@gmail.com by explaining what you are interested in from a partnership with me and how my analysis skillset can be useful to you and your project's needs.

Casual virtual coffee chats to discuss the latest industry news or even better to learn from your past experiences in the industry are greatly appreciated, too.

So, what are you waiting for?

Shoot that DM (or email)!

taplio

The Battle

Luke Judge - hundo

Thanos Tsagkadouras⚡

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?